Conduct↦Ethics and Laws↦Inspections and Audits↦Audit Conduct
What is it? Why is it important?
An audit is a systematic examination of study activities conducted by the SP-INV to verify study compliance.
The SP-INV can perform an audit at:
- A participating study site
- A study partner or service provider (e.g. data management, statistic, laboratory, laboratory, pharmacy)
The SP-INV can initiate an audit at a study site based on:
- Mismanagement issues and poor study oversight (e.g. poor handling of IMP / IMD and Biological Material, staff training and responsibilities)
- Findings during site monitoring (e.g. loss of data, protocol compliance issues, poor ISF filing)
- Suspicion of misconduct (e.g. non-compliance with the study protocol)
More
The decision to conduct an audit is weighed against the study`s Critical to Quality factors, such as the ongoing:
- Safety of study participants (e.g. safety laws)
- Quality of study data
Circumstances that may trigger a SP-INV audit:
- Detected irregularities during study monitoring (e.g. non-compliance issues with the study protocol)
- Higher risk studies (e.g. Swissmedic with risk-category B or C studies)
- Inclusion of study participants (e.g. large recruitment numbers, vulnerable population)
- Study type and complexity (e.g. multi-centre, blinded and randomised studies)
- The risk level of the study (e.g. first-in-man, placebo controlled studies)
What do I need to do?
When preparing for an audit, the SP-INV:
- Notifies the Site-INV/partner/service provider of the upcoming audit
- Provides the auditee with the purpose and scope of the audit
- Selects independent auditors (i.e. independent from the study or service) to perform the audit
- Prepares, in collaboration with auditors, an audit agenda and an audit plan (i.e. audit focus and how to conduct the audit)
- If applicable, requests documents for review, prior to the audit
In the event of a site audit, the Site-INV:
- Prepares the study team
- Reviews site documents / quality processes to ensure they are complete, up to date, and correctly filed (e.g.study essential documents, ISF)
- Reviews local quality processes to ensure they are properly implemented (e.g. handling IMP / IMD and Biological Material)
- Reviews study training and responsibilities (e.g. Site-Delegation-Log)
Where can I get help?
Your local Research Support Centre↧ can assist you with experienced staff regarding this topic
Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch
Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch
Bern, Department of Clinical Research (DCR), dcr.unibe.ch
Geneva, Clinical Research Center (CRC), crc.hug.ch
Lausanne, Clinical Research Center (CRC), chuv.ch
St. Gallen, Clinical Trials Unit (CTU), h-och.ch
Zürich, Clinical Trials Center (CTC), usz.ch
References
ICH GCP E6(R3) – see in particular guidelines
- 2.3.5 Investigator responsibilities
- 2.12.14 Investigator records
- 2.3.5 Sponsor responsibilities
- 3.9 Sponsor Oversight
- 3.11.2 Audit
- 3.12 Noncompliance